Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
Vivek P. Chavda, Vasso Apostolopoulos
Maturitas (2022) Vol. 158, pp. 78-81
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

SARS‐CoV‐2 variants and vulnerability at the global level
Vivek P. Chavda, Aayushi Patel, Darsh D. Vaghasiya
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2986-3005
Open Access | Times Cited: 109
The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
Vivek P. Chavda, Rajashri Bezbaruah, Kangkan Deka, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1926-1926
Open Access | Times Cited: 73
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 432-432
Open Access | Times Cited: 51
Protein subunit vaccines: Promising frontiers against COVID-19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 15
Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena
Vivek P. Chavda, Rajashri Bezbaruah, Mansi Athalye, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 759-759
Open Access | Times Cited: 55
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Therapeutic monoclonal antibodies for COVID-19 management: an update
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 53
Global impact of delta plus variant and vaccination
Vivek P. Chavda, Vasso Apostolopoulos
Expert Review of Vaccines (2022) Vol. 21, Iss. 5, pp. 597-600
Open Access | Times Cited: 50
Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
Vivek P. Chavda, Vasso Apostolopoulos
Vaccines (2022) Vol. 10, Iss. 3, pp. 367-367
Open Access | Times Cited: 47
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants
Vivek P. Chavda, Disha Valu, Palak K. Parikh, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 374-374
Open Access | Times Cited: 30
Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients
Cheng‐Zhao Weng, Rongcheng Xie, Guanjie Han, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 649-662
Open Access | Times Cited: 28
Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
Divya Teli, Pankti C. Balar, Kishan Patel, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 309-309
Open Access | Times Cited: 28
COVID-19 and vaccination: myths vs science
Vivek P. Chavda, Yangmin Chen, Jayant Dave, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 11, pp. 1603-1620
Closed Access | Times Cited: 34
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
Zoufang Huang, Vivek P. Chavda, Lalitkumar K. Vora, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Pseudoscience and fraudulent products for COVID-19 management
Vivek P. Chavda, Shreya S. Sonak, Nafesa K. Munshi, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 42, pp. 62887-62912
Open Access | Times Cited: 29
Therapeutics to Tackle Omicron Outbreak
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Murali M. Yallapu, et al.
Immunotherapy (2022) Vol. 14, Iss. 11, pp. 833-838
Open Access | Times Cited: 27
Effectiveness of Paxlovid, an Oral Antiviral Drug, Against the Omicron BA.5 Variant in Korea: Severe Progression and Death Between July and November 2022
Jong-Mu Kim, Min‐Gyu Yoo, Soon Jong Bae, et al.
Journal of Korean Medical Science (2023) Vol. 38, Iss. 27
Open Access | Times Cited: 12
Monkeypox: a new face of outbreak
Vivek P. Chavda, Lalitkumar K. Vora, Vasso Apostolopoulos
Expert Review of Vaccines (2022) Vol. 21, Iss. 11, pp. 1537-1540
Open Access | Times Cited: 18
The Vaccine World of COVID-19: India’s Contribution
Vivek P. Chavda, Disha R. Vihol, Hetvi K. Solanki, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1943-1943
Open Access | Times Cited: 18
Ayurvedic and Other Herbal Remedies for Dengue: An Update
Vivek P. Chavda, Anup Kumar, Rittwika Banerjee, et al.
Clinical Complementary Medicine and Pharmacology (2022) Vol. 2, Iss. 3, pp. 100024-100024
Open Access | Times Cited: 16
Comparison of clinical outcomes, demographic, and laboratory characteristics of hospitalized COVID‐19 patients during major three waves driven by Alpha, Delta, and Omicron variants in Tehran, Iran
Zahra Heydarifard, Nazanin Zahra Shafiei Jandaghi, Moslem Safaei, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 8
Open Access | Times Cited: 9
Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 management
Vivek P. Chavda, Aayushi Patel, Lalitkumar K. Vora, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 10, pp. 1395-1403
Closed Access | Times Cited: 13
Co-Infection Associated with SARS-CoV-2 and Their Management
Vivek P. Chavda, Aayushi Patel, Anjali Pandya, et al.
Future Science OA (2022) Vol. 8, Iss. 9
Open Access | Times Cited: 11
A Review on the Impact of the SARS-CoV-2 Omicron Subvariant on Elderly Patients with Diverse Co-Morbidities
Avinash Khadela, Shruti Soni, Kaivalya Megha, et al.
Biologics (2023) Vol. 3, Iss. 2, pp. 138-157
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top